David Stearns Evaluates Stability of Revamped Mets Roster
David Stearns has made it clear this offseason that the New York Mets will not retain the underperforming roster from 2025. As the president of baseball operations for the team, Stearns has been proactive in reshaping the lineup. He has pivoted from initial plans to secure star players like Bo Bichette and Jorge Polanco, demonstrating flexibility in the team’s strategy.
Key Changes in the Mets’ Roster
Among the notable consistent figures are Francisco Lindor and Juan Soto, who serve as the foundational elements of the revised team. Their roles, however, are undergoing some alterations as the Mets prepare for the upcoming season. Soto will transition to left field, while Lindor is facing potential surgery for a stress reaction in his left hamate bone.
Injury Updates
Stearns addressed the press before the start of spring training, providing updates on Lindor and the team’s strategy moving forward. He noted that a medical examination scheduled for Wednesday might result in surgery for Lindor, although he downplayed the severity of the situation.
- Francisco Lindor: May require surgery on his left hamate bone.
- Juan Soto: Transitioning to left field for the upcoming season.
- Bo Bichette: Considered but not secured by the Mets for a high salary.
- Jorge Polanco: Discussed as a potential player but not acquired.
Soto’s Transition to Left Field
Juan Soto has been working out in left field this offseason. The decision comes as many discussions took place between the player and the team. The Mets believe this shift will not negatively impact his performance, despite the change from right to left field.
With these updates, the Mets are looking to stabilize their roster with strategic changes. The team’s commitment to improving its performance reflects their determination to build a competitive lineup for the upcoming season.
